Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

BACKGROUND: Although stereotactic radiotherapy (SRT) for vestibular schwannoma has demonstrated excellent local control rates, hearing deterioration is often reported after treatment. We therefore wished to assess the change in hearing loss after SRT and to determine which patient, tumor and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: van Linge, A., van Os, R., Hoekstra, N., Heijmen, B., Stienstra, L., Dallenga, A., Wolbers, J., Mendez Romero, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304756/
https://www.ncbi.nlm.nih.gov/pubmed/30583739
http://dx.doi.org/10.1186/s13014-018-1202-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304756/
https://www.ncbi.nlm.nih.gov/pubmed/30583739
http://dx.doi.org/10.1186/s13014-018-1202-z

Ejemplares similares